Bryan Lau, PhD
615 N. Wolfe Street
Baltimore , Maryland 21205
PhD , Johns Hopkins Bloomberg School of Public Health , 2004
ScM , Johns Hopkins Bloomberg School of Public Health , 1999
MHS , Johns Hopkins Bloomberg School of Public Health , 1999
My research interests include epidemiological and statistical methods for cohort (both clinical and interval) studies and application of these methods primarily to HIV cohort studies. I have specific interest in developing new methods as well as adapting approaches from other fields as novel solutions to specific epidemiologic questions. Examples include competing risk methodologies and extension to comparing multiple event types, random forests, bootstrap model averaging and multimodel inference
Dr. Lau is involved with multiple ongoing studies including the North American AIDS Cohort Collaboration of Research and Design (NA-ACCORD), an International Epidemiologic Databases to Evaluate AIDS [IeDEA] initiative sponsored by NIAID), the Johns Hopkins HIV Clinical Cohort Study, the ALIVE Study, the CFAR Network of Integrated Clinical Systems (CNICS), is a co-director for Biostatistics and Epidemiology Methods Core of the Johns Hopkins CFAR, and in addition collaborates with many other investigators across the University.
Epidemiologic Methods, Biostatistics, Observational Studies, HIV/AIDS
Lau B, Cole SR, Gange SJ. Parametric mixture models to evaluate and summarize hazard ratios in the presence of competing risks with time-dependent hazards and delayed entry. Statistics in Medicine 2010 (in press)
Neblett RC, Hutton HE, McCaul ME, Moore RD, Lau B, Chander G. Alcohol Consumption among HIV-infected women: Impact on time to antiretroviral therapy and survival. Journal of Women’s Health 2010 (in press)
Althoff KN, Justice AC, Gange SJ, Deeks SG, Saag MS, Silverberg MJ, Gill MJ, Lau B, Napravnik S, Tedaldi E, Klein M, Gebo K. Virologic and immunologic response to highly active antiretroviral therapy, by age and regimen class. AIDS 2010 (in press)
Lau B, Chander G, Gange SJ, Moore RD. Identifying Individuals with Virologic Failure After Initiating HAART: The Surprising Value of Mean Corpuscular Hemoglobin. AIDS Research and Therapy 2010; 7:25.
Lucas GM, Chaudhry A, Hsu J, Woodson T, Lau B, Olsen Y, Keruly JC, Fiellin DA, Finkelstein R, Barditch-Crovo P, Cook K, Moore RD. Clinic-based Treatment for Opioid-dependent HIV-infected Patients versus Referral to an Opioid Treatment Program: A Randomized Controlled Trial. Annals of Internal Medicine 2010; 152:704-711.